R&T News: Salt; Boceprevir; ANA598; INX-189; and More

[Guest guest]

Dear D,

This Research & Treatment News update gives you highlights from the latest articles posted to Hepatitis-Central.com for patients and their families, caregivers and health professionals. With new information being published regularly, we want you to have the latest news on treatments, clinical trials, social issues and important breakthroughs.

Hep C Advisory: Where Salt Hides

Also known as salt, sodium is overly abundant in many common foods – an abundance that could put someone with advanced Hepatitis C infection in peril. Read more.

Boceprevir Officially Fast-Tracked

In the U.S. and Europe, Boceprevir’s entrance into the market is being accelerated due to its effectiveness against Hepatitis C. Read more.

Hepatitis C Drug ANA598 Moves to Phase IIb

Along with Health Canada, the United States Food and Drug Administration has cleared the protocol for Anadys’ Phase IIb Hepatitis C study of ANA598 in combination with pegylated interferon and ribavirin. Read more.

Early Hepatitis C Trial Data Shows INX-189 to Be Effective

Interim data from a Phase 1b trial of Inhibitex’s INX-189 demonstrates potent antiviral activity against the Hepatitis C virus. Read more.

Hepatitis C Protein Interaction Identified

Scripps researchers have identified a protein that interacts with the Hepatitis C virus to enable replication. Since blocking this interaction could impair the virus’ ability to reproduce, Scripps’ discovery could lead to a new focus for the next generation of Hepatitis C drugs. Read more.

Update on Pharmasset's Hepatitis C Drug Candidates

Pharmasset has released interim study results for several of its Hepatitis C drugs that are in different stages of testing. Read more.

IP-10 Protein Levels Predict Hepatitis C Treatment Outcome

Investigators have discovered that blood levels of a specific protein appear to foretell of Hepatitis C treatment success or failure. Read more.

Your Opinion Wanted:

Salt can be sneaky, abundant in curious places. Such is the case for the following four food groups. Of the four, which do you or will you start to avoid to reduce your consumption of sodium?

SodaSoupBeansCondiments and SaucesAll of the AboveNone of the Above

VISIT the Salt and Sodium poll today.

We asked, you responded:

Eating a healthy breakfast takes on extra importance throughout the cold winter months. Consuming oatmeal offers many benefits, including aiding toxin elimination, reducing cholesterol and improving blood sugar levels. Do you eat oatmeal for breakfast?

49%: Yes, I eat oatmeal for breakfast many times a week.32%: Yes, I occasionally eat oatmeal for breakfast.13%: No, I never eat oatmeal for breakfast or any other meal.6%: No, I don’t eat oatmeal for breakfast but would like to start.

To learn more about the benefits of eating oatmeal – as well as which hot breakfast foods to avoid – click here.

To learn even more about Hepatitis C and what you can do about it, visit Hepatitis-Central.com. You'll find more than 2,750 pages of in-depth information for HCV patients and their families, caregivers and health professionals. If you would like to review an article you saw in one of these recent Research & Treatment News updates, or would like to search through any of the archived, in-depth news and commentary pages, you ought to browse Hepatitis C Information Central at Hepatitis-Central.com.

Note: LiverSupport Health News, our “sister†e-newsletter, gives you valuable lifestyle suggestions and news-you-can-use from our LiverSupport.com editors. Just click here to sign up for LiverSupport Health News, and learn even more about supporting liver health for you and your family.

Yours in health,Editors@...www.Hepatitis-Central.com1-800-364-5722

Do you have a friend or relative who would find the information in this Research & Treatment News update useful? You can forward this email to them, so they can begin reading all the latest hepatitis research and liver support news. If you're not a current subscriber, click here to sign up today. Hepatitis-Central.com2331 State Route 17KMontgomery, NY 125491-800-364-5722